Cancer Diagnostics – News and Features

A vaccine has shown the potential to prevent the relapse of KRAS-mutated pancreatic and colorectal cancers in a phase I trial.

The diagnostic, which requires only a simple urine test to read the results, could make lung cancer screening more accessible worldwide.

Precision medicine and immunotherapy have the potential to revolutionize cancer treatment, but challenges must be addressed to ensure their smooth integration into clinical practice.

Progress in the search for biomarkers to help predict, manage and assess treatment of acute kidney injury has been reported by researchers.

Bio-Rad's Jeremiah McDole explores the benefits of bringing molecular testing in-house and how ddPCR technology can be applied in oncology workflows.

Using a liquid biopsy to detect circulating tumor DNA and analyze immune cells helps to predict patient response to immunotherapy in lung cancer patients.

Lymphatic fluid from surgical drains is usually thrown away, but researchers have discovered that it contains a biomarker that can guide head and neck cancer treatment.

Circulating tumor DNA predicts recurrence and splits disease into two subgroups in Stanford Medicine-led study of Hodgkin lymphoma. New drug targets or changes in treatments may reduce toxicity.

Secreted frizzled-related protein 2 – a protein that promotes tumor growth and angiogenesis – has been associated with poor outcomes in pancreatic cancer patients.

This article explores how biopharmaceutical organizations seeking to remain competitive must adopt innovations, like cell-free long DNA synthesis, to unleash the potential of synthetic biology and accelerate therapeutic development across all facets of genetic medicine.